Torrent Pharmaceuticals Q4 PAT may dip 37.3% YoY to Rs. 129.3 cr: Edelweiss

Edelweiss has come out with its fourth quarter (Jan-March’ 18) earnings estimates for the Pharma sector. The brokerage house expects Torrent Pharmaceuticals to report net profit at Rs. 129.3 crore down 37.3% year-on-year (down 12.2% quarter-on-quarter).

Net Sales are expected to increase by 11.5 percent Y-o-Y (up 8.3 percent Q-o-Q) to Rs. 1,599.4 crore, according to Edelweiss.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 18.8 percent Y-o-Y (down 2.3 percent Q-o-Q) to Rs. 3506 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.